BioSpace News Archive

A new survey by the International Atherosclerosis Society (IAS) provided a ‘snapshot’ of the gaps in knowledge among clinicians that limit best practice.

Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing.

Four-day event builds on knowledge-sharing momentum established by COVID-19 webcast series and DIA Now

PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Thermo Fisher Scientific for the development and manufacturing of PMC-309, a next-generation immune checkpoint blockade to treat cancer.

Photocure ASA (OSE: PHO), held its annual general meeting on 10 June 2020 at 17:00 hours (CET). All proposals were resolved as presented in the notice convening the annual general meeting dated 19 May 2020 , as further set out in the minutes from the general meeting attached hereto. For further information, please contact:

NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has launched a marketing initiative focusing on chronic knee pain. This effort includes direct-to-consumer digital marketing as well as informing physicians and other health care providers about the use of Quell for their patients with knee pain. About one-quarter of U.S. adults suffer from frequent knee pain, which limits function, decreases mobility, impacts sleep and reduces quality

Ryvu Therapeutics (WSE: RVU) today reported its first quarter 2020 financial results and provided a corporate update. “Q1 2020 was an exciting and eventful time for Ryvu. We have managed to achieve several important milestones including clinical ones, such as the successful completion of Phase I for SEL24/MEN1703 in acute myeloi

California Life Sciences Association, the trade association representing California’s life sciences sector, announced that it has been coordinating with the Office of Emergency Services for the State of California to help essential life sciences companies obtain Personal Protective Equipment.

National Jewish Health continues to increase its testing capabilities for COVID-19 antibodies, including the addition of new validated testing equipment.

bioAffinity Technologies, Inc. is a privately held company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment.